Gene · 4998
Papers2,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer. | Curr Oncol | 2023 | 38248100 | PubTator, text mining | PubMed |
| Role of autophagy in cancer-associated fibroblast activation, signaling and metabolic reprograming. | Front Cell Dev Biol | 2023 | 38234683 | PubTator, text mining | PubMed |
| The DNA Alkyltransferase Family of DNA Repair Proteins: Common Mechanisms, Diverse Functions. | Int J Mol Sci | 2023 | 38203633 | PubTator, text mining | PubMed |
| G-Quadruplexes in Human Telomere: Structures, Properties, and Applications. | Molecules | 2023 | 38202757 | PubTator, text mining | PubMed |
| Tsc1 Loss in VIP-Lineage Cortical Interneurons Results in More VIP+ Interneurons and Enhanced Excitability. | Cells | 2023 | 38201256 | PubTator, text mining | PubMed |
| Therapeutic targeting of p90 ribosomal S6 kinase. | Front Cell Dev Biol | 2023 | 38169775 | PubTator, text mining | PubMed |
| Pan-cancer analysis of homeodomain-containing gene C10 and its carcinogenesis in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 38154103 | PubTator, text mining | PubMed |
| TMX family genes and their association with prognosis, immune infiltration, and chemotherapy in human pan-cancer. | Aging (Albany NY) | 2023 | 38147024 | PubTator, text mining | PubMed |
| Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma. | Front Immunol | 2023 | 38143740 | PubTator, text mining | PubMed |
| Exploring Thiazolopyridine AV25R: Unraveling of Biological Activities, Selective Anti-Cancer Properties and In Silico Target and Binding Prediction in Hematological Neoplasms. | Molecules | 2023 | 38138609 | PubTator, text mining | PubMed |
| Lipofuscin, Its Origin, Properties, and Contribution to Retinal Fluorescence as a Potential Biomarker of Oxidative Damage to the Retina. | Antioxidants (Basel) | 2023 | 38136230 | PubTator, text mining | PubMed |
| Comprehensive Analysis of METTLs (METTL1/13/18/21A/23/25/2A/2B/5/6/9) and Associated mRNA Risk Signature in Hepatocellular Carcinoma. | Anal Cell Pathol (Amst) | 2023 | 38130905 | PubTator, text mining | PubMed |
| Macrophage polarization in spinal cord injury repair and the possible role of microRNAs: A review. | Heliyon | 2023 | 38125535 | PubTator, text mining | PubMed |
| An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancer. | Front Immunol | 2023 | 38124743 | PubTator, text mining | PubMed |
| Identification of central genes for endometriosis through integration of single-cell RNA sequencing and bulk RNA sequencing analysis. | Medicine (Baltimore) | 2023 | 38115253 | PubTator, text mining | PubMed |
| A comprehensive analysis of the prognostic and immunotherapeutic characteristics of KIFC1 in pan-cancer and its role in the malignant phenotype of pancreatic cancer. | Aging (Albany NY) | 2023 | 38112634 | PubTator, text mining | PubMed |
| Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia. | Blood Cancer J | 2023 | 38110349 | PubTator, text mining | PubMed |
| Layered mechanisms regulating the human mitochondrial NAD+ transporter SLC25A51. | Biochem Soc Trans | 2023 | 38108469 | PubTator, text mining | PubMed |
| Comprehensive Analysis Reveals the Potential Roles of CDKN3 in Pancancer and Verification in Endometrial Cancer. | Int J Gen Med | 2023 | 38106976 | PubTator, text mining | PubMed |
| Microgravity triggers ferroptosis and accelerates senescence in the MG-63 cell model of osteoblastic cells. | NPJ Microgravity | 2023 | 38104197 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4998/papers?page=10